Oncocyte Corp COO Albert Parker's 2020 pay jumps 54% to $1.4M
Oncocyte Corp reports 2020 executive compensation
By ExecPay News
Published: May 21, 2021
Oncocyte Corp reported fiscal year 2020 executive compensation information on May 21, 2021.
In 2020, four executives at Oncocyte Corp received on average a compensation package of $1.1M, a 15% decrease compared to previous year.
Average pay of disclosed executives at Oncocyte Corp
Albert P. Parker, Chief Operating Officer, received $1.4M in total, which increased by 54% compared to 2019. 38% of Parker's compensation, or $530K, was in option awards. Parker also received $133K in bonus, $1.1K of change in pension value and nonqualified deferred compensation earnings, $349K in salary, as well as $386K in other compensation.
Mitchell Levine, Chief Financial Officer, received a compensation package of $1.1M, which decreased by 9% compared to previous year. 48% of the compensation package, or $504K, was in option awards.
Ronald Andrews, Chief Executive Officer, earned $1M in 2020, a 49% decrease compared to previous year.
Padma Sundar, Senior Vice President, Marketing and Market Access, received $908K in 2020, which increases by 17% compared to 2019.
Related executives
You may also like
Source: SEC filing on May 21, 2021.